Daiken Biomedical Co., Ltd. (TPE:7780)
Taiwan · Delayed Price · Currency is TWD 16.70
+0.10 (0.60%)
At close: Aug 6, 2026
Daiken Biomedical Market Cap
Daiken Biomedical has a market cap or net worth of 13.53 billion as of August 7, 2026. Its market cap has decreased by -41.74% in one year.
Market Cap
13.53B
Enterprise Value
8.21B
Revenue
2.02B
Ranking
n/a
PE Ratio
35.65
Stock Price
16.70
ChartMarket Cap Chart
Since October 28, 2024, Daiken Biomedical's market cap has increased from 10.68B to 13.53B, an increase of 26.66%. That is a compound annual growth rate of 14.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 13.53B | -6.96% |
| Dec 31, 2025 | 14.54B | 33.88% |
| Dec 31, 2024 | 10.86B | 1.69% |
| Oct 28, 2024 | 10.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Charoen Pokphand Enterprise (Taiwan) | 31.69B |
| Lian Hwa Foods | 26.23B |
| Standard Foods | 26.21B |
| TTET Union | 24.88B |
| Ve Wong | 11.29B |
| Tehmag Foods | 9.45B |
| Microbio | 8.47B |
| Namchow Holdings | 8.26B |